Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Sale | 2024-03-05 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $34 | $85,000 | 11,500 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:03 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $37.75 | $110,041 | 98,458 (Indirect Direct) | View |
| 2021-12-28 Purchase | 2024-02-13 4:05 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 3,433 | $12.96 | $44,476 | 5,197 (Indirect Direct) | View |
| 2021-12-28 Purchase | 2024-02-13 4:00 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 3,433 | $12.96 | $44,476 | 3,433 (Indirect) | View |
| 2024-01-16 Sale | 2024-01-18 4:10 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $37.97 | $110,683 | 97,940 (Direct) | View |
| 2023-12-26 Sale | 2023-12-28 4:00 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 100,000 | $42.06 | $4,206,000 | 1,100,065 (Indirect Direct) | View |
| 2023-12-18 Sale | 2023-12-20 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,000 | $40 | $80,000 | 14,000 (Indirect Direct) | View |
| 2023-12-15 Sale | 2023-12-19 4:00 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $36.12 | $105,290 | 100,855 (Direct) | View |
| 2023-12-01 Sale | 2023-12-05 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $29.4 | $73,500 | 16,000 (Indirect Direct) | View |
| 2023-11-17 Sale | 2023-11-20 4:00 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 22,685 | $29.1 | $660,059 | 301,575 (Direct) | View |
| 2023-11-17 Sale | 2023-11-20 4:00 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 51,552 | $29.1 | $1,500,038 | 7,341,089 (Indirect Direct) | View |
| 2023-11-15 Sale | 2023-11-17 4:09 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $30 | $87,450 | 103,770 (Direct) | View |
| 2023-09-05 Sale | 2023-09-07 4:00 pm | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 2,500 | $30 | $75,000 | 18,500 (Indirect Direct) | View |
| 2023-08-17 Sale | 2023-08-18 4:00 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 22,683 | $28.59 | $648,455 | 346,571 (Direct) | View |
| 2023-08-17 Sale | 2023-08-18 4:00 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 51,552 | $28.59 | $1,473,784 | 7,443,338 (Indirect Direct) | View |
| 2023-07-18 Sale | 2023-07-19 9:33 pm | BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Parent GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 1,500,000 | $35 | $52,500,000 | 25,120,991 (Indirect) | View |
| 2023-05-17 Sale | 2023-05-18 4:07 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 51,552 | $14.01 | $722,218 | 7,545,588 (Indirect Direct) | View |
| 2023-05-17 Sale | 2023-05-18 4:02 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 24,424 | $14.01 | $342,168 | 391,263 (Direct) | View |
| 2023-05-03 Sale | 2023-05-05 4:03 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 120,000 | $14.18 | $1,701,744 | 6,821,605 (Indirect Direct) | View |
| 2023-05-03 Sale | 2023-05-05 4:01 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 64,929 | $14.18 | $920,693 | 36,408 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-12 Option Award | 2024-03-14 4:00 pm | N/A 2034-03-11 | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 358,728 | $0 | 358,728 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-14 4:00 pm | N/A 2034-03-11 | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 122,720 | $0 | 122,720 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 89,992 | $0 | 282,777 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 18,919 | $37.21 | 282,777 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 3,760 | $0 | 1,230,085 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:04 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 1,509 | $37.21 | 1,230,085 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-21 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 204,498 | $0 | 7,293,167 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 47,922 | $37.21 | 7,293,167 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 98,458 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 4:03 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 98,458 (Direct) | View |
Ownership | 2024-02-13 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 0 | $0 | 5,197 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 4:10 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 97,940 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 4:10 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 97,940 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 100,855 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:00 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 100,855 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 89,992 | $0 | 301,575 (Direct) | View |
| 2023-11-16 Tax Withholding | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 22,311 | $28.86 | 301,575 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 204,498 | $0 | 7,341,089 (Direct) | View |
| 2023-11-16 Tax Withholding | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 50,697 | $28.86 | 7,341,089 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 3,760 | $0 | 1,230,756 (Direct) | View |
| 2023-11-16 Tax Withholding | 2023-11-20 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 1,301 | $28.86 | 1,230,756 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 4:09 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $8.45 | 103,770 (Direct) | View |
| 2023-11-15 Exercise | 2023-11-17 4:09 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,915 | $0 | 103,770 (Direct) | View |
| 2023-08-16 Exercise | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 3,760 | $0 | 1,232,057 (Direct) | View |
| 2023-08-16 Tax Withholding | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 1,301 | $29.8 | 1,232,057 (Direct) | View |
| 2023-08-16 Exercise | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 89,988 | $0 | 346,571 (Direct) | View |
| 2023-08-16 Tax Withholding | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 22,311 | $29.8 | 346,571 (Direct) | View |
| 2023-08-16 Exercise | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 204,500 | $0 | 7,443,338 (Direct) | View |
| 2023-08-16 Tax Withholding | 2023-08-18 4:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 50,698 | $29.8 | 7,443,338 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:25 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:24 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:23 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:22 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:21 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:20 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:19 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:18 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:17 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:16 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:15 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:14 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director | 51,501 | $0 | 51,501 (Direct) | View |
| 2023-05-16 Tax Withholding | 2023-05-18 4:07 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 50,697 | $14.09 | 7,545,588 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 4:07 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President | 204,498 | $0 | 7,545,588 (Direct) | View |
| 2023-05-16 Tax Withholding | 2023-05-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 1,300 | $14.09 | 1,232,107 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 3,759 | $0 | 1,232,107 (Direct) | View |
| 2023-05-16 Tax Withholding | 2023-05-18 4:02 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 20,572 | $14.09 | 391,263 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 4:02 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO | 89,992 | $0 | 391,263 (Direct) | View |